P4801Antithrombotic management in patients with atrial fibrillation and acute coronary syndromes

Authors:

Abstract
Introduction: Antithrombotic therapy in patients with atrial fibrillation (AF) who present with an acute coronary syndrome (ACS) present a challenge given the need for combining antiplatelet (oftentimes dual therapy) with anticoagulation therapy. Triple antithrombotic therapy (TAT) increases the risk of bleeding and therefore remains a much-debated issue. Based on a large national registry we investigated antithrombotic practices and its prognostic value in patients with ACS accompanied by AF.